Biontech and instadeep announce strategic collaboration and form ai innovation lab to develop novel immunotherapies

Mainz, germany and london, united kingdom, november 25, 2020 (globe newswire) -- biontech se (nasdaq: bntx, “biontech”) and instadeep ltd today announced a multi-year strategic collaboration aimed at applying the latest advances in artificial intelligence (ai) and machine learning (ml) technology to develop novel immunotherapies for a range of cancers and infectious diseases.
BNTX Ratings Summary
BNTX Quant Ranking